Improving early palliative care for Black women with metastatic breast cancer
Official title: The Development and Evaluation of a Community-Based, Early Palliative Care Intervention for Black Women with Metastatic Breast Cancer
Funded at Icahn School of Medicine at Mount Sinai · NIH-10988297 · Data updated 2026-11-12
This study is testing a new support program designed for Black women with metastatic breast cancer, where community members help provide care and understanding for the unique challenges they face.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | December 20, 2021 |
| Project end | November 30, 2026 |
| Funding year | 2025 |
| Award (this year) | $188,692 |
| NIH project number | 5K08CA267309-04 |
| Project ID | NIH-10988297 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Black women diagnosed with metastatic breast cancer who may benefit from early palliative care interventions.
✕Less likely to help
Patients who do not identify as Black women or those without a diagnosis of metastatic breast cancer may not receive benefit from this research.
What this research studies
This research focuses on developing and evaluating a community-based early palliative care intervention specifically for Black women suffering from metastatic breast cancer. The approach involves engaging community members as lay navigators to provide support and address the unique psychological and physical challenges faced by these patients. The study will gather insights through focus groups to tailor the intervention, followed by a pilot randomized controlled trial to assess its feasibility and preliminary effectiveness.
Why it matters
Potential benefit: If successful, this research could significantly improve the quality of life and care outcomes for Black women with metastatic breast cancer.
How similar studies have gone: While early palliative care is a growing field, this specific approach targeting Black women with metastatic breast cancer is novel and has not been extensively tested in prior research.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Mazor, Melissa — Icahn School of Medicine at Mount Sinai
- Study coordinator: Mazor, Melissa
Related research
Other NIH-funded projects on the same topics.
-
Targeted palliative care for people with metastatic breast cancer
This program offers a short series of focused palliative care visits to people with metastatic breast cancer who are likely to have limited time left.
-
Improving end-of-life care for patients with metastatic breast cancer
This study is looking to improve the care and support for people with metastatic breast cancer by helping them and their doctors talk better about their wishes and needs as they near the end of life, so they can get the best care possible.
-
Understanding FGFR1-amplified breast cancer to overcome endocrine resistance
This project explores why a type of breast cancer with FGFR1 changes stops responding to hormone therapy and looks for new combination treatments that may help patients live longer.
-
Oral fulvestrant as the next standard of care for ER+ metastatic breast cancer
A new oral formulation of fulvestrant is being tested to help people with ER-positive metastatic breast cancer have a longer, better-tolerated response to treatment.
-
Fit2ThriveMB: A digital activity program to help people with metastatic breast cancer feel better and stay active
A digital, at-home physical activity program designed for people with metastatic breast cancer to improve quality of life and daily functioning.
-
Acupuncture to ease symptoms for people with metastatic breast cancer
A clinical trial will test whether weekly acupuncture for 12 weeks can reduce symptom burden for people with metastatic breast cancer who are on standard therapy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.